Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.17%
1,106.36
-1.87
-0.17%
—1,108.231,109.651,115.881,105.59——
SIXC
Communications
SIXC
Communications
SIXC
+0.77%
610.29
+4.66
+0.77%
—605.63605.63611.69602.96——
SIXE
Energy
SIXE
Energy
SIXE
+0.10%
1,211.22
+1.27
+0.10%
—1,209.951,210.981,212.701,197.20——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.43%
1,750.71
-7.52
-0.43%
—1,758.231,759.031,760.641,739.69——
SIXM
Financials
SIXM
Financials
SIXM
-1.07%
628.17
-6.77
-1.07%
—634.94632.49632.49627.63——
SIXR
Staples
SIXR
Staples
SIXR
+0.26%
854.57
+2.20
+0.26%
—852.37850.81859.97849.13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.90%
216.87
-1.98
-0.90%
—218.85218.85218.85215.61——
SIXT
Technology
SIXT
Technology
SIXT
+0.95%
3,561.94
+33.45
+0.95%
—3,528.493,565.203,578.773,509.18——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.26%
903.31
-11.51
-1.26%
—914.82910.36910.36897.78——
SIXV
Health care
SIXV
Health care
SIXV
+0.63%
1,481.54
+9.27
+0.63%
—1,472.271,470.891,484.151,466.47——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.39%
2,399.95
+9.34
+0.39%
—2,390.612,387.312,409.702,373.97——
ICUI:NASDAQ
ICU Medical Inc
$122.04
-0.97%
(-1.19) 1D
$122.04
0.00% (0.00)
After hours
Closed: May 13, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ICUI...
Open
$122.25
High
$125.01
Low
$121.30
Mkt. cap
3.05B
Avg. vol.
270.88K
Volume
312.62K
P/E ratio
65.90
52-wk high
$160.28
52-wk low
$107.02
EPS
$1.85
Beta
0.74
Shares outstanding
24.99M
No. of employees
13K
News stories
From sources across the web
Profile
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
About ICU Medical Inc
CEOVivek Jain
Employees13K
Founded1984
HeadquartersSan Clemente, California, United States
SectorMedical device
Websiteicumed.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$1.97 / $1.76
+11.80%beat
Revenue / Est. (USD)
530.22M / 533.74M
-0.66%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
548.87M
536.99M
540.70M
530.22M
Cost of goods sold
340.80M
336.11M
337.72M
324.00M
Cost of revenue
340.80M
336.11M
337.72M
324.00M
Research and development expenses
21.87M
21.25M
21.09M
21.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
159.39M
152.77M
155.81M
154.57M
Operating expense
181.26M
174.02M
176.90M
175.85M
Total operating expenses
522.06M
510.13M
514.62M
499.84M
Operating income
26.80M
26.86M
26.09M
30.38M
Other non operating income
-68.00K
238.00K
-32.00K
-17.00K
EBT including unusual items
36.52M
-4.05M
-18.39M
-4.58M
EBT excluding unusual items
10.97M
7.57M
4.75M
12.35M
Income tax expense
1.18M
-658.00K
-2.65M
-34.71M
Effective tax rate
3.23%
16.23%
14.43%
757.62%
Other operating expenses
-
-
-
-
Net income
35.34M
-3.40M
-15.73M
30.13M
Net profit margin
6.44%
-0.63%
-2.91%
5.68%
Earnings per share
2.10
2.03
1.91
1.97
Interest and investment income
2.52M
2.42M
2.14M
2.04M
Interest expense
-23.06M
-22.23M
-22.78M
-18.53M
Net interest expenses
-20.55M
-19.81M
-20.64M
-16.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
76.47M
77.66M
76.92M
80.41M
Gain or loss from assets sale
-41.77M
-1.51M
2.69M
136.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer